1 / 5

Global Ocular Pain Market – Industry Trends and Forecast to 2029

Global Ocular Pain Market, By Disease Type (Ocular Pain with Eye Diseases and Ocular Pain without Primary Eye Diseases), Type (Diagnosis and Treatment), Application (Conjunctivitis, Corneal Abrasion, Blepharitis, Sty, Iritis, Sinusitis, Migraines, Glaucoma, and Others), Route of Administration (Topical, Periocular, Intraocular, Oral and Others), Drug Type (Prescription and Over the Counter), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospit

pawarmnk
Download Presentation

Global Ocular Pain Market – Industry Trends and Forecast to 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Ocular Pain Market – Industry Trends and Forecast to 2029 Ocular Pain Market Analysis and Size The global ocular pain market is expected to witness significant growth during the forecast period. The market comprises of numerous key players who are focusing on research and development activities to formulate novel drugs and involve new therapies for the effective treatment. The major market players are involved in licensing and patenting due to the increasing demand for novel and effective drugs across the globe. The rising awareness among people for eye-related diseases and more and more cases of ocular migraine is further boosting the market growth. COVID-19 also had a major impact on the market growth. https://www.databridgemarketresearch.com/reports/global-ocular-pain-market  Data Bridge Market Research analyses a growth rate in the global ocular pain market in the forecast period 2022-2029. The expected CAGR of global ocular pain market is tend to be around 8% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

  2. Report Description Market Definition Ocular pain which is also known as eye pain, usually occurs due to mild irritation, but it is rarely a symptom of a serious condition. Normally the pain gets subsided without medicine or further treatment, and recovers automatically by the self-immune system. Although, ocular pain having primary ophthalmic disorders requires timely treatment. Often ocular pain is treated with eye drops and topical steroids or NSAIDs. Drivers Increase in Elderly Population The global ocular pain market is expected to witness a heavy growth rate in the forecast period driven by the factor of an aging population. The increasing demand in the global ocular pain market is a replication of the growing elderly population, as people aged over 60 years frequently develop conditions in which eyes have reduced elasticity, affecting the normal functioning. This boost the market growth. Increased Product Launches Rising strategies such as new product launches could help the major market players gain a competitive edge over the other players. For instance, Dextenza is the first FDA-approved intracanalicular insert, which volunteers the drug to the surface of the eye without the requirement for eye drops. Another one is Lotemax SM which was approved in February 2019, to treat postoperative inflammation and pain following ocular surgery. This boosts the market growth https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

  3. Market Overview Ocular Pain Market Scope Disease Type Ocular Pain with Eye Diseases Ocular Pain without Primary Eye Diseases Application Conjunctivitis Corneal Abrasion Blepharitis Sty Iritis Sinusitis Migraines Glaucoma Others Route of Administration Topical Periocular Intraocular Oral Others https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

  4. Key Players • Key players operating in the global ocular pain market include: • Aerie Pharmaceuticals, Inc. (U.S.) • Merck & Co. Inc. (U.S.) • Pfizer Inc. (U.S.) • Teva Pharmaceutical Industries Ltd. (Israel) • Alcon (Switzerland) • Bayer AG (Germany) • Amgen Inc. (U.S.) • Carl Zeiss Meditec AG (Germany) • HumanOptics Holding AG (Germany) • Sun Pharmaceuticals Industries Ltd. (India) • Amneal Pharmaceuticals LLC. (U.S.) • Alvogen (U.S.) • Bausch Health Companies Inc. (U.S.) • Ocular Therapeutix, Inc. (U.S.) • IACTA Pharmaceuticals, Inc (U.S.) https://www.databridgemarketresearch.com/reports/global-ocular-pain-market

  5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Contact Us:- Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email:- corporatesales@databridgemarketresearch.com

More Related